Vitiligo
Age: 18 years and older Sponsor: Pfizer
Location: Rancho Santa Margarita
More Information: Pfizer Clinical Trials Website
Clinical Trial for Vitiligo
We are conducting clinical studies on new treatments for Vitiligo. If you or anyone you know has been diagnosed with Vitiligo and is interested in participating in a clinical trial, please complete our short form at the bottom of the page to determine your eligibility. A member of our team of medical professionals will then contact you to ask a few questions. Please be aware that the consultation is free, and there are no obligations.
Study Details
Sponsor: Pfizer
Summary: Please contact our team for more details on this study.
Title: A Phase 3 Randomized, Double-Blind, 52-Week Placebo-Controlled Multi-Center Study with A Double-Blind 52-Week Extension Period with Randomized Dose Up/Dose Down Titration Investigating the Efficacy, Safety, and Tolerability of Ritlecitinib in Adult Participants with Nonsegmental Vitiligo
Key words: Ritlecitinib, Vitiligo, Nonsegmental Vitiligo